Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis. [electronic resource]
Producer: 20140901Description: 990-7 p. digitalISSN:- 2151-4658
- Abatacept
- Aged
- Antibodies, Monoclonal, Murine-Derived -- adverse effects
- Antirheumatic Agents -- adverse effects
- Arthritis, Rheumatoid -- complications
- Bacterial Infections -- epidemiology
- Comorbidity
- Female
- Glucocorticoids -- adverse effects
- Hospitalization
- Humans
- Immunoconjugates -- adverse effects
- Incidence
- Male
- Middle Aged
- Retrospective Studies
- Risk Assessment
- Rituximab
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- United States -- epidemiology
- Veterans -- statistics & numerical data
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.